➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Dow
McKesson
Boehringer Ingelheim
Merck

Last Updated: May 8, 2021

DrugPatentWatch Database Preview

Drug Price Trends for TEMAZEPAM

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drug Price Trends for TEMAZEPAM

Average Pharmacy Cost for TEMAZEPAM

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
TEMAZEPAM 7.5 MG CAPSULE 68084-0549-21 1.27296 EACH 2021-03-17
TEMAZEPAM 15 MG CAPSULE 00228-2076-10 0.07813 EACH 2021-03-17
TEMAZEPAM 15 MG CAPSULE 00228-2076-50 0.07813 EACH 2021-03-17
TEMAZEPAM 15 MG CAPSULE 00378-4010-05 0.07813 EACH 2021-03-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for TEMAZEPAM

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
TEMAZEPAM 7.5MG CAP Major Pharmaceuticals 00904-6436-60 100 167.43 1.67430 EACH 2019-08-01 - 2023-11-30 FSS
TEMAZEPAM 7.5MG CAP Major Pharmaceuticals 00904-6436-60 100 68.47 0.68470 EACH 2019-10-23 - 2023-11-30 FSS
TEMAZEPAM 7.5MG CAP Major Pharmaceuticals 00904-6436-60 100 60.97 0.60970 EACH 2020-02-01 - 2023-11-30 FSS
TEMAZEPAM 7.5MG CAP UD Major Pharmaceuticals 00904-6436-04 3X10 74.91 2019-04-18 - 2023-11-30 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Express Scripts
Johnson and Johnson
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.